We are live on
!
Find out more
CD
Chapin Davis Portfolio holdings
AUM
$520M
Turnover
15.11%
1-Year Est. Return
117.57%
This Fund
S&P 500
This Quarter
Est. Return
+13.49%
1 Year Est. Return
+117.57%
3 Year Est. Return
+339.14%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$449M
AUM Growth
+$21.9M
(+5.1%)
Cap. Flow
-$2.61M
Cap. Flow
% of AUM
-0.58%
Top 10 Holdings %
Top 10 Hldgs %
27.98%
Holding
273
New
29
Increased
94
Reduced
89
Closed
12
Avg Time Held
2.2
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keysight
KEYS
|
+$8.88M |
| 2 |
Lam Research
LRCX
|
+$8.82M |
| 3 |
Ciena
CIEN
|
+$7.02M |
| 4 |
Moderna
MRNA
|
+$5.86M |
| 5 |
CF Industries
CF
|
+$5.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$11.6M |
| 2 |
Amphenol
APH
|
+$6.86M |
| 3 |
Palantir
PLTR
|
+$6.84M |
| 4 |
Broadcom
AVGO
|
+$6.83M |
| 5 |
Idexx Laboratories
IDXX
|
+$5.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.28% |
| 2 | Miscellaneous | 20.35% |
| 3 | Financials | 8.07% |
| 4 | Industrials | 7.58% |
| 5 | Healthcare | 6.91% |
Similar funds
AIS
SWM
CFA
VP
CFG
MWM
LCWP
WS
Chapin Davis's Q1 2026 Portfolio in Review
As of Q1 2026, Chapin Davis held 273 positions worth $449M, up 5.1% from $427M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Chapin Davis's Q1 2026 filing shows 29 new, 94 increased, 89 reduced and 12 closed positions. Its largest new stake was Keysight: 35,434 shares worth $10M. The largest sale was Micron Technology, an estimated $11.6M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Miscellaneous and Financials.
- Chapin Davis's largest Q1 2026 buy was Keysight: 35,434 shares worth $10M.
- Chapin Davis added most to Teradyne in Q1 2026, an estimated $2.84M increase.
- Chapin Davis's biggest Q1 2026 reduction was Micron Technology, cutting an estimated $11.6M.
- Chapin Davis fully exited Idexx Laboratories in Q1 2026, selling an estimated $5.54M.
- Chapin Davis's ten largest holdings make up 28% of its $449M portfolio in Q1 2026.
- Chapin Davis opened 29 new positions and closed 12 in Q1 2026.
- Chapin Davis's portfolio value rose 5.1% quarter-over-quarter to $449M.
Based on Chapin Davis's 13F filing for Q1 2026, filed 21 Apr 2026.